Literature DB >> 23552981

Disease modification in systemic sclerosis. Do integrated approaches offer new challenges?

M Cutolo1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23552981     DOI： 10.1007/s00393-013-1157-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  30 in total

1.  Idiopathic pulmonary fibrosis is associated with endothelial to mesenchymal transition.

Authors:  Dilip Nataraj; Armin Ernst; Raghu Kalluri
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08       Impact factor: 6.914

2.  Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions.

Authors:  Vanessa Smith; Filip De Keyser; Carmen Pizzorni; Jens T Van Praet; Saskia Decuman; Alberto Sulli; Ellen Deschepper; Maurizio Cutolo
Journal:  Ann Rheum Dis       Date:  2010-10-21       Impact factor: 19.103

Review 3.  Mechanisms of vascular damage in systemic sclerosis.

Authors:  Ulf Müller-Ladner; Oliver Distler; Lidia Ibba-Manneschi; Elena Neumann; Steffen Gay
Journal:  Autoimmunity       Date:  2009-11       Impact factor: 2.815

4.  Disease-modifying drugs for systemic sclerosis: why have we not found them yet?

Authors:  Chris T Derk
Journal:  Expert Rev Clin Immunol       Date:  2011-07       Impact factor: 4.473

5.  Bosentan fosters microvascular de-remodelling in systemic sclerosis.

Authors:  S Guiducci; S Bellando Randone; C Bruni; G Carnesecchi; A Maresta; F Iannone; G Lapadula; M Matucci Cerinic
Journal:  Clin Rheumatol       Date:  2012-09-29       Impact factor: 2.980

6.  Validation of potential classification criteria for systemic sclerosis.

Authors:  Sindhu R Johnson; Jaap Fransen; Dinesh Khanna; Murray Baron; Frank van den Hoogen; Thomas A Medsger; Christine A Peschken; Patricia E Carreira; Gabriela Riemekasten; Alan Tyndall; Marco Matucci-Cerinic; Janet E Pope
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

Review 7.  [Capillaroscopy and rheumatic diseases: state of the art].

Authors:  M Cutolo; A Sulli; M E Secchi; C Pizzorni
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

8.  Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial.

Authors:  Annegret Kuhn; Merle Haust; Vincent Ruland; Ramona Weber; Pablo Verde; Gerd Felder; Christian Ohmann; Kristina Gensch; Thomas Ruzicka
Journal:  Rheumatology (Oxford)       Date:  2010-04-05       Impact factor: 7.580

9.  Timing of transition between capillaroscopic patterns in systemic sclerosis.

Authors:  Alberto Sulli; Carmen Pizzorni; Vanessa Smith; Giuseppe Zampogna; Francesca Ravera; Maurizio Cutolo
Journal:  Arthritis Rheum       Date:  2012-03

Review 10.  Microvascular remodeling and wound healing: a role for pericytes.

Authors:  Brian M Dulmovits; Ira M Herman
Journal:  Int J Biochem Cell Biol       Date:  2012-06-28       Impact factor: 5.085
View more
  2 in total

1.  Therapy. Optimized treatment algorithms for digital vasculopathy in SSc.

Authors:  Maurizio Cutolo; Alberto Sulli
Journal:  Nat Rev Rheumatol       Date:  2015-08-11       Impact factor: 20.543

2.  Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay.

Authors:  Maurizio Cutolo; Stefano Soldano; Paola Montagna; Amelia Chiara Trombetta; Paola Contini; Barbara Ruaro; Alberto Sulli; Stefano Scabini; Emanuela Stratta; Sabrina Paolino; Carmen Pizzorni; Vanessa Smith; Renata Brizzolara
Journal:  Arthritis Res Ther       Date:  2018-07-27       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.